NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Ekso Bionics Holdings Inc (F: 23E2)
23E2 Technical Analysis
5
As on 23rd Jun 2025 23E2 STOCK Price closed @ 3.31 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.23 & Strong Buy for SHORT-TERM with Stoploss of 1.87 we also expect STOCK to react on Following IMPORTANT LEVELS. |
23E2STOCK Price
Open | 3.31 | Change | Price | % |
High | 3.31 | 1 Day | 0.00 | 0.00 |
Low | 3.31 | 1 Week | 0.00 | 0.00 |
Close | 3.31 | 1 Month | 2.97 | 873.53 |
Volume | N/A | 1 Year | 1.81 | 120.67 |
52 Week High 3.31 | 52 Week Low 0.01 |
F Germany Most Active Stocks
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
ENB | 47.60 | -0.92% |
TEF | 3.84 | -0.52% |
TEF | 3.84 | -0.52% |
WHL | 5150.00 | -0.44% |
WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
23E2 Daily Charts |
23E2 Intraday Charts |
Whats New @ Bazaartrend |
23E2 Free Analysis |
|
23E2 Important Levels Intraday
RESISTANCE | 3.31 |
RESISTANCE | 3.31 |
RESISTANCE | 3.31 |
RESISTANCE | 3.31 |
RESISTANCE | 3.31 |
RESISTANCE | 3.31 |
RESISTANCE | 3.31 |
RESISTANCE | 3.31 |
23E2 Forecast June 2025
4th UP Forecast | 4.77 |
3rd UP Forecast | 4.3 |
2nd UP Forecast | 4.01 |
1st UP Forecast | 3.72 |
1st DOWN Forecast | 2.9 |
2nd DOWN Forecast | 2.61 |
3rd DOWN Forecast | 2.32 |
4th DOWN Forecast | 1.85 |
23E2 Weekly Forecast
4th UP Forecast | 5.87 |
3rd UP Forecast | 5.05 |
2nd UP Forecast | 4.54 |
1st UP Forecast | 4.03 |
1st DOWN Forecast | 2.59 |
2nd DOWN Forecast | 2.08 |
3rd DOWN Forecast | 1.57 |
4th DOWN Forecast | 0.75 |
23E2 Forecast2025
4th UP Forecast | 9.67 |
3rd UP Forecast | 7.63 |
2nd UP Forecast | 6.37 |
1st UP Forecast | 5.11 |
1st DOWN Forecast | 1.51 |
2nd DOWN Forecast | 0.25 |
3rd DOWN Forecast | -1.01 |
4th DOWN Forecast | -3.05 |
Ekso Bionics Holdings Inc ( F Germany Symbol : 23E2 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
23E2 Other Details
Segment | EQ | |
Market Capital | 43795556.00 | |
Sector | Healthcare | |
Industry | Medical Instruments & Supplies | |
Offical website | > echo $website ; ?> |
23E2 Address
![]() |
23E2 Latest News
23E2 Business Profile
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California. Address: 1414 Harbour Way South, Richmond, CA, United States, 94804
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service